Neurona Therapeutics Advances Rezanecel Toward Phase 3 After 97% Median Seizure Reduction in Long-Term Epilepsy Data 2 months ago AnaIn Clinical TrialsTop Stories
GSK Bets $10.6 Billion on Lung Cancer as Nuvalent Acquisition Reshapes Oncology Pipeline 2 months ago AnaIn DealsFunding RoundsPartnershipsTop Stories
Australia Approves Amtagvi as First T Cell Immunotherapy for Advanced Melanoma, Targeting the World’s Highest-Burden Population 2 months ago AnaIn Biopharma HighlightsBreaking NewsClinical TrialsTop Stories
FDA Clears First PROTAC Therapy in Oncology: Vepdegestrant Approved for ESR1-Mutated Advanced Breast Cancer 2 months ago AnaIn Clinical TrialsResearch Updates
NewLimit Raises $435 Million Series C to Advance Epigenetic Reprogramming Platform Targeting Age-Related Disease 2 months ago AnaIn Clinical TrialsDealsInvestmentsPartnerships
FDA Grants Dual Approval to Trastuzumab Deruxtecan in Early-Stage HER2-Positive Breast Cancer, Extending ADC Dominance 2 months ago AnaIn Breaking NewsClinical TrialsTop Stories
Shionogi’s Ensitrelvir Becomes First Oral Antiviral Approved for Post-Exposure COVID-19 Prevention 2 months ago AnaIn Clinical TrialsPharma Industry UpdatesResearch Updates
Tortugas Neuroscience Launches with $106 Million to Advance Four Clinical-Stage CNS Programs Licensed from Eisai and Hansoh 2 months ago AnaIn DealsFunding RoundsResearch UpdatesTop Stories
BioMarin Reports Positive Phase 3 Data for VOXZOGO in Hypochondroplasia 2 months ago AnaIn Biopharma HighlightsBreaking NewsClinical TrialsTop Stories
FDA Approves VEPPANU (Vepdegestrant), First Oral PROTAC Therapy for ESR1-Mutated Breast Cancer 2 months ago AnaIn Biopharma HighlightsBreaking NewsResearch Updates
Alzheimer’s Drug Pipeline Reaches Record Scale in 2026 With 192 Active Trials 2 months ago AnaIn Breaking NewsResearch UpdatesTop Stories
Biotech M&A Reaches $106 Billion in 2026 as Pharma Giants Race to Fill Pipelines 2 months ago AnaIn Breaking NewsBreakthroughsTop StoriesVenture Capital
Early Alzheimer’s Egg-Shell Protein Therapy Shows Promise in Small Human Study 11 months ago AnaIn Clinical TrialsStartups
Ultragenyx Gene Therapy Rejected by FDA Even as Takeda Scores Big in Narcolepsy Trial 1 year ago AnaIn Clinical TrialsFDA Approvals
FDA Rejects UltraGeneX’s Gene Therapy Application, Pivotal Phase III Reads Out for Takeda Narcolepsy Drug 1 year ago AnaIn Breaking NewsFDA Approvals
